Arch Therapeutics Inc (ARTH): Price and Financial Metrics
ARTH Price/Volume Stats
| Current price | $0.26 | 52-week high | $9.00 |
| Prev. close | $0.19 | 52-week low | $0.17 |
| Day low | $0.19 | Volume | 9,800 |
| Day high | $0.30 | Avg. volume | 6,598 |
| 50-day MA | $0.27 | Dividend yield | N/A |
| 200-day MA | $1.18 | Market Cap | 1.22M |
ARTH Stock Price Chart Interactive Chart >
Arch Therapeutics Inc (ARTH) Company Bio
Arch Therapeutics, Inc. operates as a life science medical device company. The company develops products based on its technology to stop bleeding and control leaking, as well as provides other advantages during surgery and trauma care. Its primary product candidate is AC5 Devices, a biocompatible synthetic peptide that comprises naturally occurring amino acids to achieve hemostasis in minimally invasive and open surgical procedures. The company was founded in 2006 and is based in Framingham, Massachusetts.
ARTH Price Returns
| 1-mo | 30.00% |
| 3-mo | N/A |
| 6-mo | -70.80% |
| 1-year | -96.85% |
| 3-year | -98.78% |
| 5-year | -99.47% |
| YTD | -96.41% |
| 2023 | 39.23% |
| 2022 | -72.63% |
| 2021 | -36.62% |
| 2020 | -39.94% |
| 2019 | -52.91% |
Loading social stream, please wait...